← Sticker Wall MODEL · DETAIL

Telomere Testing and NAD+ Infusion Annual Membership Chain

1) Annual membership fees covering basic testing and consultations; 2) Additional charges for NAD+ infusion sessions on

MODEL

Key Fields

FIELD STAMPS

IndustryHealthcare / Elderly Care

RegionGlobal

ScaleMid-size

ChannelHybrid

📌 Background

The longevity clinic sector continues to heat up in 2026, with high-net-worth individuals willing to pay premium fees for anti-aging services. Telomere testing serves as a quantifiable aging metric, forming a closed-loop 'testing plus intervention' model with NAD+ infusions. Industry estimates suggest the domestic market size reached approximately 480 billion to 700 billion RMB in 2025, with a growth rate of 15% to 25%. Over 57 companies have entered the space, and in the first half of 2025, 18 companies completed financing totaling nearly 700 million RMB. In terms of international benchmarks, a single treatment session at a Mayfair clinic in London costs approximately 2,500 GBP.

👤 Target Customers

High-net-worth individual clients, particularly entrepreneurs, executives, and professionals over 40 who are focused on anti-aging and health management.

💰 Revenue Streams

1) Annual membership fees covering basic testing and consultations; 2) Additional charges for NAD+ infusion sessions on a per-treatment or package basis; 3) Value-added service fees for telomere test report interpretation and personalized anti-aging plans.

🧮 Cost Structure

Procurement costs for medical equipment and testing reagents; labor costs for registered nurses and physicians; clinic rental and renovation expenses; compliant procurement costs for NAD+ infusion drugs; marketing and customer acquisition costs.

🛡️ Moat

The combination of telomere testing and NAD+ infusions creates a data-driven anti-aging closed loop; licensed medical institution credentials and professional medical teams establish regulatory barriers; accumulation of high-net-worth member data drives repeat purchases and referrals.

🔑 Keys to Success

Maintain compliant medical credentials and establish a team of endorsed physicians.
Utilize telomere testing data to create differentiated anti-aging solutions.
Use an annual membership system to lock in clients and increase retention rates.

⚠️ Risks

NAD+ infusions being classified as off-label use or non-compliant medical practice.
Client dissatisfaction with treatment efficacy leading to refund requests or legal disputes.
Unscientific interpretation of telomere test results leading to a collapse in trust.

🏢 Cases

Swiss CLP Beijing Longevity Center
Global longevity clinic annual membership models
Tru Niagen NAD+ longevity business

📊 SWOT Analysis

Strengths

Telomere testing provides quantifiable aging data, enhancing client trust.
Annual subscription model locks in the long-term value of high-net-worth clients.
NAD+ infusion treatments have high average transaction values with clear profit margins.

Weaknesses

NAD+ infusion efficacy lacks large-scale clinical evidence, leading to skepticism.
Telomere testing has low standardization, resulting in variations in result interpretation.
High customer acquisition costs for high-net-worth segments and heavy reliance on word-of-mouth.

Opportunities

Rising popularity of the longevity clinic sector reduces market education costs.
Growing health anxiety and anti-aging demand among high-net-worth individuals.
Potential for traffic-driving partnerships with insurance companies and high-end physical examination institutions.

Threats

Regulatory policies tightening on the compliance of NAD+ infusions.
Low-cost, gray-market NAD+ infusions disrupting market pricing.
Entry of large medical institutions or pharmaceutical companies into the longevity clinic sector.

Sources